Page last updated: 2024-11-04

sb 202190 and Lymphoma

sb 202190 has been researched along with Lymphoma in 2 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niiya, M1
Niiya, K1
Shibakura, M1
Asaumi, N1
Yoshida, C1
Shinagawa, K1
Teshima, T1
Ishimaru, F1
Ikeda, K1
Tanimoto, M1
Vockerodt, M1
Pinkert, D1
Smola-Hess, S1
Michels, A1
Ransohoff, RM1
Tesch, H1
Kube, D1

Other Studies

2 other studies available for sb 202190 and Lymphoma

ArticleYear
Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Oncology, 2004, Volume: 67, Issue:3-4

    Topics: Blotting, Northern; Blotting, Western; Butadienes; Carcinoma, Small Cell; Caspase 3; Caspases; Cell

2004
The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation.
    International journal of cancer, 2005, Apr-20, Volume: 114, Issue:4

    Topics: Amino Acid Motifs; Blotting, Western; CD40 Antigens; Cell Line, Tumor; Dactinomycin; Enzyme Activati

2005